Medication info
Zocor 40mg (Simvastatin)

Zocor 40mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›40mg / 1 tablet
Manufacturer / importer
Organon Korea Co., Ltd.
Appearance
Oval film-coated tablet, red brick color with MSD749 engraved on one side
Packaging
30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 200807528 · Notified 2008.07.07 · Insurance code 073100260

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to coronary heart disease, diabetes, peripheral vascular disease, stroke, or a history of other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is limited to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor closely.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Importer
Organon Korea Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hyperlipidemia
  • primary hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of hyperlipidemia and cardiovascular diseases. First, it helps decrease the risk of cardiovascular events in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or who are at high risk. It also regulates cholesterol levels within the normal range for patients with primary hypercholesterolemia and mixed dyslipidemia, improving cardiovascular health. Notably, it is effective in reducing total cholesterol and LDL cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia, along with dietary management. This medication normalizes blood lipid levels, aiding in the prevention and treatment of cardiovascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to coronary heart disease, diabetes, peripheral vascular disease, stroke, or a history of other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is limited to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor closely.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication may cause muscle-related side effects such as myopathy and rhabdomyolysis, so caution is necessary, especially when taking high doses. Patients with liver dysfunction or active liver disease should not take this medication. It is safest for pregnant women or those who may become pregnant, as well as nursing mothers, to avoid this medication. The risk of muscle side effects increases when taken with certain strong medications, so consultation with a physician is required when taking such medications. Patients with a history of alcohol abuse or liver and kidney dysfunction should exercise additional caution while taking this medication and report immediately to healthcare providers if they experience muscle pain or weakness. Elderly individuals and women are at higher risk for muscle-related side effects and should be cautious while taking this medication. Regular monitoring of liver function and muscle status during the use of this medication is advisable. Any potential interactions with other medications, health supplements, or grapefruit juice should be discussed with healthcare providers prior to use. If unexplained muscle pain, tenderness, or weakness occurs during the use of this medication, inform a doctor immediately and potentially stop taking the medication. Additionally, this medication may increase blood sugar levels, so patients at risk for diabetes should regularly monitor their blood glucose levels. This medication is not recommended for children, especially those under 10 years of age, and adolescents over 10 years should take it under medical guidance. This medication should be stored out of reach of children, and it is advisable to keep it in its original container.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 83 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste disorder
  • extraocular muscle movement disorder
  • facial paralysis
  • tremors
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • severe myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • eye muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • pancreatitis
  • loss of appetite
  • vomiting
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • thrombocytopenia
  • peripheral nerve disorder

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or humidity ingress and kept away from direct sunlight at a cool room temperature below 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Oval film-coated tablet, red brick color with MSD749 engraved on one side

Package unit

30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.